2025 Proffered Presentations
S204: THE ROLE OF DTI IN SURGICAL MANAGEMENT OF BRAINSTEM CAVERNOUS MALFORMATIONS: A META-ANALYSIS OF 4,159 CASES
Brandon M Edelbach, BS1; Ahmad K AlMekkawi, MD2; Ananya Sharma, BS3; Nikitha Sheth, BS3; Paras Shah, BS3; Eshanika Manchanda, BS3; Carlos A Bagley, MD, MBA2; Jonathan D Breshears, MD2; Yifei Duan, MD2; 1Loma Linda Univeristy School of Medicine; 2Saint Luke's Marion Bloch Neuroscience Institute Department of Neurosurgery; 3Univeristy of Missouri-Kansas City School of Medicine
Objective: To compare outcomes of diffusion tensor imaging (DTI) versus conventional magnetic resonance imaging (MRI) or computed tomography (CT) in the surgical management of brainstem cavernous malformations (BSCM).
Methods: A systematic review and meta-analysis of 106 studies, including 4,159 patients with BSCM, was conducted. Patients were stratified into two cohorts: those who received DTI/DTT (n=382) and those who received only MRI/CT (n=3,777). Primary outcomes included gross total resection rates, clinical improvement, and worsening.
Results: The DTI/DTT cohort demonstrated a significantly higher gross total resection rate compared to the MRI/CT cohort (94.9% vs. 87.0%, p=0.025). Clinical improvement was observed in 71.5% of the DTI/DTT group versus 65.6% in the MRI/CT group (p=0.343). The DTI/DTT group showed a significantly lower rate of clinical worsening (5.1% vs. 11.4%, p=0.038). No significant differences were found in complication rates between the two groups (45.0% vs. 36.1%, p=0.394). Multivariate regression analysis revealed that medullary location negatively impacted gross total resection rates in the DTI/DTT cohort (p=0.0293).
Conclusion: The use of DTI/DTT in the surgical management of BSCM is associated with higher gross total resection rates and lower rates of clinical worsening compared to conventional MRI/CT alone.
Variable | DTI/DTT | MRI/CT | P-value |
Age (years) | 37.83±10.26 | 37.87±12.02 | .988 |
Male-Female ratio | 0.877±0.66 | 0.875±075 | .989 |
mRS Score | 1.87±0.51 | 2.55±0.91 | .015 |
Motor Deficits (%) | 55.8 | 49.2 | .559 |
CN Deficits (%) | 87.0 | 62.9 | .263 |
Midbrain (%) | 22.5 | 25.3 | .643 |
Pons (%) | 61.6 | 58.02 | .659 |
Medulla (%) | 14.0 | 19.4 | .387 |
Size of Major Diameter (mm) | 15.96±4.45 | 18.4±4.93 | .172 |
Variable | DTI/DTT | MRI/CT | P-value |
Follow-up (months) | 92.02±107.8 | 133.9±114.2 | .184 |
GTR (%) | 94.9±5.09 | 87.0±25.1 | .025 |
Improved (%) | 71.5±22.4 | 65.6±25.5 | .343 |
Worse (%) | 5.1±9.7 | 11.4±15.6 | .038 |
Complications (%) | 45.0 | 36.1 | .394 |
Predictor | Estimate | SE | p-value |
Age | -0.1238 | 0.1152 | .3430 |
Male to Female Ratio | -0.2487 | 1.6799 | .8895 |
Motor Deficits | -0.1669 | 0.2716 | .5722 |
CN neuropathy | 0.6930 | 0.2554 | .0534 |
Midbrain | -1.2540 | 0.5673 | .0916 |
Pons | 0.1803 | 0.2430 | .4994 |
Medulla | -1.3769 | 0.4141 | .0293 |